Clinical Trials Logo
  1. Home
  2. Post Partum Haemorrhage
  3. NCT02900690

Health Economics Evaluation of the Management of Severe Postpartum Hemorrhage: Comparison of Recombinant Activated Factor VII Strategy to the Reference Strategy

Post Partum Haemorrhage Clinical Trial

Clinical Trial Summary

The main objective of this project is to assess the average cost of the treatment of bleeding postpartum with recombinant activated factor VII (NovoSeven®) and compare it to the reference strategy. Costs related to medicine NovoSeven® can generate surplus, but it also avoids in some cases very costly invasive procedures. It will be interesting to compare the average cost of the complete strategies supported.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02900690
Study type Observational
Source Centre Hospitalier Universitaire de Nimes
Contact
Status Terminated
Phase
Start date April 22, 2010
Completion date November 5, 2010
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT02303418 - Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Undergoing Caesarean Sections for Placenta Previa: A Randomised Controlled Trial Phase 3
Recruiting NCT00344929 - Severe Post Partum Haemorrhage (PPH): A Randomized Trial on Transversal Intervention in 6 French Perinatal Networks N/A
Not yet recruiting NCT05336838 - Improving Management of Post-partum Haemorrhage With Quantra® System
Completed NCT02775773 - Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH Phase 3
Completed NCT02216383 - Intramuscular Oxytocics: A Randomised Control Trial Phase 3
Completed NCT01571323 - Combined Use of Oxytocin and Misoprostol Versus Oxytocin Infusion and Misoprostol Alone to Reduce Blood Loss at Cesarean Section Phase 1/Phase 2
Terminated NCT02908126 - Compare Efficacy of Oxytocin Administrations on Postpartum Uterine Contractility Phase 1